Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-17-004176)

Filing Details

Accession Number:: 0001179110-17-004176
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-07 19:05:22
Reporting Period:: 2017-03-03

Filing Date:: 2017-03-07
Accepted Time:: 2017-03-07 19:05:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583107	Theravance Biopharma Inc.	TBPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1302448	J Bradford Shafer	C/O Theravance Biopharma Us, Inc. 901 Gateway Boulevard South San Francisco CA 94080	Evp, Gen. Counsel, Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2017-03-03	26,829	$31.86	161,453	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was executed in multiple trades at prices from $31.86 to $31.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transactions set forth in footnotes (1) through (3) to this Form 4 were effected.